Robert Rubin

Advisor, Board of Advisors | LINKEDIN

Mr. Robert Rubin is an experienced professional in corporate development and mergers and acquisitions (M&A). He served in Sterling Drug, Inc. as Director of Corporate Development. Pior, Mr. Rubin was Director of Corporate Development at Revlon, Inc. where he directed the company’s diversification from its core beauty

business into the healthcare business. Additionally, he served in Citibank, where as a Vice President he managed all phases of a $500 million loan portfolio.

 

Since transitioning to the B2G sector, Mr. Rubin is a senior leader in M&A and other investment banking services for the technology arena, with a focus on companies involved in government contracting.

Contract Vehicles

GSA Schedules:

GSA IT-70 (SINs 132-51 and 
132-56)

STARS II (GS00Q17GWD2228) (For more information, please email our STARS II Program Manager at stars2@dsfederal.com)

Professional Services Schedule (SIN 874-1 & 874-7)

HCaTS  SB (Pool 2)

Other Vehicles:

CMS SPARC (JV)

CIO-SP3 8(a) & CIO-SP3 SB

FDA Integrated Services (IS) BPA

HRSA Technical Assistance IDI

PSC IDIQ

USAMRIID IDIQ

VA-T4 8(a)

Awards

2019 Montgomery County Business Hall of Fame 

2019 NAGC Blue Pencil/Gold Screen Award of Excellence

2017 Montgomery County Chamber of Commerce Small Business Leader of the Year 

2017 Washington Business Journal Top Small Technology Company

2017 Washington Business Journal "Women Who Mean Business"

2017 Top 100 MBE

Credentials

Certified Woman-Owned Small Business (#WOSB2000515)

CMMI-DEV Level 3

CMMI-SVC Level 3

ISO 9001:2015

DCAA-Compliant Accounting System